Navigation Links
ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA
Date:9/10/2007

5 (b)(2) NDA covering ANX-514, ADVENTRX must certify that all applicable Taxotere patents have expired prior to the manufacture, use or sale of ANX-514.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases. The Company seeks to improve the performance and safety of existing treatments by addressing significant problems such as drug metabolism, bioavailability, excessive toxicity and treatment resistance. More information can be found on the Company's web site at http://www.adventrx.com.

Forward Looking Statement

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors that, if they do not materialize or prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that preclinical and clinical results are not indicative of the success of subsequent clinical trials and that products will not perform as preclinical and clinical data suggests or as otherwise anticipated; difficulties or delays in developing, testing, manufacturing and marketing and obtaining regulatory approval for ANX-514, including receiving necessary regulatory approvals for clinical trials of ANX-514 and the potential for automatic injunctions regarding FDA approval of ANX-514 and other challenges by patent holders during the Section 505(b)(2) process; uncertainty under Section 505(b)(2) resulting from legal action against the FDA and the potential that future interpretations of Section 505(b)(2) could delay or prevent the FDA from app
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The next session of Clinovo’s TechTrainings ... comprise of the increasingly popular ‘Base SAS’ and ‘CDISC ... series of technical hands-on classes for entry-level to experienced ... next step in their professional careers. , The 9-week ... Kang, Senior Statistician at Genentech and former Senior Statistician ...
(Date:7/21/2014)... of tension to a chain of carbon atoms can ... according to Rice University scientists. , Stretching the material ... carbon atoms -- by just 3 percent can begin ... find useful for mechanically activated nanoscale electronics and optics. ... and his colleagues appears in the American Chemical Society ...
(Date:7/21/2014)... 2014 ResearchMoz presents this ... USA Cancer Biomaker Market to 2018 ... ResearchMoz presents this most up-to-date research on Global ... Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, ... GLOBAL & USA ...
(Date:7/19/2014)... United States Non-Vascular Stents Market Outlook ... "United States Non-Vascular Stents Market Outlook to 2020", ... Non-Vascular Stents market. The report provides value, in ... average prices (in US dollars) within market segments ... Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially ...
Breaking Biology Technology:Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3Carbyne morphs when stretched 2Carbyne morphs when stretched 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4
... Researchers at Duke University Medical Center, Beth Israel Deaconess ... to HIV vaccine design that uses an altered form of ... researchers showed that they could design HIV envelopes that could ... enhanced immune response in an animal model. Immature B cells ...
... new paradigm in quantum information processing has been demonstrated ... published in this week,s issue of Science Express ... integrated circuit that implements the quantum von Neumann architecture. ... can be programmed using a quantum central processing unit, ...
... Md., Sept. 1, 2011 Neuralstem, Inc. (NYSE Amex: ... Richard Garr will present at the 2011 Stifel Nicolaus ... a.m. EDT. Garr will discuss the Company,s opportunities and ... and will be providing an update on the ongoing ...
Cached Biology Technology:New HIV vaccine approach targets desirable immune cells 2New HIV vaccine approach targets desirable immune cells 3Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference 2Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference 3
(Date:7/21/2014)... 21, 2014 (Toronto) As part of a multinational, ... Mental Health (CAMH) have helped identify over 100 locations ... developing schizophrenia, in what is the largest genomic study ... published online in Nature , point to biological ... lead to new approaches to treating the disorder, which ...
(Date:7/21/2014)... seals, every movement, researchers have shown for the first ... wind farms and pipelines. Those man-made structures probably serve ... a study published in the Cell Press journal ... was shocked when I first saw the stunning grid ... offshore wind farm in the United Kingdom, says Deborah ...
(Date:7/21/2014)... A University of California, San Diego School of Medicine-led ... not recognize the potentially serious health consequences of childhood ... in helping their child reach a healthy weight. , ... of the Academy of Nutrition and Dietetics . , ... and physical activity behaviors," said lead author Kyung Rhee, ...
Breaking Biology News(10 mins):International team sheds new light on biology underlying schizophrenia 2International team sheds new light on biology underlying schizophrenia 3Seals forage at offshore wind farms 2Parents rank their obese children as 'very healthy' 2
... Va. (Sept. 27, 2010) -- Renowned international experts ... inhalable vaccines for human papillomavirus and tuberculosis to ... 2010 FIP Pharmaceutical Sciences World Congress (PSWC) in ... (AAPS) Annual Meeting and Exposition in New Orleans, ...
... (September 28, 2010) New findings from Van ... that help plants survive drought and other stresses in harsh ... a follow-up to findings published in Nature last ... by Science magazine. "I think that the ...
... Kavli Science Forum: 2010 in Oslo, Dr. John P. Holdren -- ... why climate change is a priority to the Obama administration, and ... to, what he termed the effects of "global climate disruption." ... any of us - as individual nations," he stated. "We need ...
Cached Biology News:New VARI findings next step to growing drought-resistant plants 2John P. Holdren addresses climate change, stressing need for international cooperation 2
Form: Ready to use Applications: ELISA...
Form: Ready to use Applications: ELISA...
ANTI S. GROUP AG:H...
Recorder REC-111 single-channel, 1. Category: Chromatography Systems & Accessories, Systems....
Biology Products: